Effects of β-Blockers on the Sympathetic and Cytokines Storms in Covid-19.
Effects of β-Blockers on the Sympathetic and Cytokines Storms in Covid-19.
复制标题
DOI:
10.3389/fimmu.2021.749291
复制
发表时间:
2021
影响因子:
7.3
通讯作者:
Batiha GE
中科院分区:
文献类型:
--
作者:
Al-Kuraishy HM;Al-Gareeb AI;Mostafa-Hedeab G;Kasozi KI;Zirintunda G;Aslam A;Allahyani M;Welburn SC;Batiha GE
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a causative virus in the development of coronavirus disease 2019 (Covid-19) pandemic. Respiratory manifestations of SARS-CoV-2 infection such as acute lung injury (ALI) and acute respiratory distress syndrome (ARDS) leads to hypoxia, oxidative stress, and sympatho-activation and in severe cases leads to sympathetic storm (SS). On the other hand, an exaggerated immune response to the SARS-CoV-2 invasion may lead to uncontrolled release of pro-inflammatory cytokine development of cytokine storm (CS). In Covid-19, there are interactive interactions between CS and SS in the development of multi-organ failure (MOF). Interestingly, cutting the bridge between CS and SS by anti-inflammatory and anti-adrenergic agents may mitigate complications that are induced by SARS-CoV-2 infection in severely affected Covid-19 patients. The potential mechanisms of SS in Covid-19 are through different pathways such as hypoxia, which activate the central sympathetic center through carotid bodies chemosensory input and induced pro-inflammatory cytokines, which cross the blood-brain barrier and activation of the sympathetic center. β2-receptors signaling pathway play a crucial role in the production of pro-inflammatory cytokines, macrophage activation, and B-cells for the production of antibodies with inflammation exacerbation. β-blockers have anti-inflammatory effects through reduction release of pro-inflammatory cytokines with inhibition of NF-κB. In conclusion, β-blockers interrupt this interaction through inhibition of several mediators of CS and SS with prevention development of neural-cytokine loop in SARS-CoV-2 infection. Evidence from this study triggers an idea for future prospective studies to confirm the potential role of β-blockers in the management of Covid-19.
登录
查看更多内容
影响因子:
5
作者:
Al-Kuraishy HM;Al-Gareeb AI;Almulaiky YQ;Cruz-Martins N;El-Saber Batiha G
通讯作者:
El-Saber Batiha G
影响因子:
5.4
作者:
Changotra, Harish;Jia, Yali;Karst, Stephanie M.
通讯作者:
Karst, Stephanie M.
影响因子:
4.3
作者:
Al-Kuraishy HM;Al-Gareeb AI;Alzahrani KJ;Cruz-Martins N;Batiha GE
通讯作者:
Batiha GE
影响因子:
6.1
作者:
Evans AK;Ardestani PM;Yi B;Park HH;Lam RK;Shamloo M
通讯作者:
Shamloo M
影响因子:
1.2
作者:
Ammar MA;Hussein NS
通讯作者:
Hussein NS